Congress Programme

Provisional program subject to change

New Date! – Please note that the conference will take place October 22, 2021 ONLY!

Thursday, October 21

TBC | General Assembly

Friday, October 22

08:45-09:00 | Opening

Chair: Deirdre Fehily, Jacinto Sánchez Ibáñez

COVID Pandemia: overview on the european level legislation

S1.1 How tissue donation can grow through resilience and network perspective – even in a pandemic
Martin Borgel, Germany 

S1.2 COVID-19 and Cardiovascular tissue banking in Europe
Ramadan Jashari, Belgium 

S1.3 Covid and substances of Human Origin. Recommendations
Dragoslav Domanovich, Sweden

S1.4 New technologies applied to Tissue Banking & Advanced Therapies training program in the time of covid-19
Alba Coll, Spain

S1.5 How Italian Tissue Banks has reacted to COVID-19 Pandemia? A.I.BA.T. experience
Paila Minghetti, Italy

09:55-10:00 | Break

Chair: Artur Kaminski, Jaime Tabera Fernandez

S2.1 tba
Irene Bello (BST), Italy

S2.2 From burn surgery to regenerative medicine: clinical outcomes of acellular dermal matrix
Marisa Pérez, Spain

S2.3 Adipose tissue transplantation
Diletta Trojan, Italy

S2.4 Denuded Descemet’s membrane as potential tool to support human embryonic stem cell derived retinal pigment epithelial cells culture
Elena Daniele, Italy

S2.5 A method to evaluate cellular viability and composition in fresh and cryopreserved adipose tissue
Francesca Favaretto, Italy

11:00-11:20 | Break

Chair: Simone Hennerbichler-Lugscheider, Diletta Trojan

S3.1 Preservation and clinical applications of human amniotic membrane in ophthalmology
Stefano Ferrari, Italy

S3.2 The use of biological membranes for correction of congenital malformations
Giulia Montagner, Italy

S3.3 Homologous amniotic membrane as a dural substitute in decompressive craniectomies
Diletta Trojan, Italy

S3.4 Implantation of amniotic membrane over pancreatic anastomosis after pancreaticoduodenectomy
Diletta Trojan, Italy

S3.5 Bilaminar Technique with Coronally Advanced Flap and Cryopreserved Human Amniotic Membrane in the Treatment of Gingival Recessions
Roberta Abate, Italy

S3.6 Human amniotic membrane in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)
Mirko Ragazzo, Italy

S3.7 Renewal of conjunctival epithelium over amniotic membrane to perform autologous simple conjunctival epithelial transplantation (SCET): in vitro validation and results of clinical application for primary pterygium
Marina Bertolin, Italy

S3.8 Success stories in the use of amniotic membrane in dermatology and ophthalmology
Nicola Hofmann, Germany

S3.9 How to prolong cellular viability of human amniotic membrane in vitro
Laura Poženel, Austria

12:35-13:35 | Lunch Break

Chair: Artur Kaminski, Richard Lomas

S4.1 New therapies for old conditions
Paul Rooney, United Kingdom

S4.2 A 10 year review of the national bone banking service in Ireland
Lauren Tiedt

Chair: Ramadan Jashari, Richard Lomas

S5.1 title – tba
Antoon van den Bogaerdt, The Netherlands

S5.2 Homograft Valves: A sixty years of a promising European therapy
Jose Luis Pomar, Spain

S5.3 Inferior vena cava reconstruction using banked vena caval homograft following resection for leiomyosarcoma
Giulia Montagner, Italy

S5.4 Application of a Statistical Analysis Tool to Monitor Microbiological Failure Rates for Heart Valve Allografts
Elisa Allen, United Kingdom

S5.5 Aortic allograft harvesting – anterior mitral valve leaflet significance
Jan Burkert, Czech Republic

14:55-15:10| Break

Chair: Jacinto Sánchez Ibáñez, Jaime Tabera

S6.1 The revision of the EU legislation on blood, tissues and cells
Deirdre Fehily, Belgium

S6.2 Ensuring quality and safety of tissues and cells for human application through European consensus standards
Mar Lomero, France 
Marta Lopez Fraga, France 

S6.3 EDQM Risk Assessment Tool for Aseptic Procurement, Processing, Storage and Distribution of Tissues and Cells for Human Application.
Johan Guns, Belgium

Chair: Stefano Ferrari, Simone Hennerbichler-Lugscheider

S7.1 The value of clinical outcome registries for determining the suitability and efficacy of tissues for human application.
John Armitage, United Kingdom

S7.2 Combining transport and surgery: the future of DMEK
Gabriela Wojcik, Italy

S7.3 Endothelial cell viability after DMEK graft preparation
Alina Miron

S7.4 LaMEK preloaded: high quality lamellar grafts preloaded in the DMEK-RAPID system for direct implantation
Nicola Hofmann, Germany 

S7.5 Sterility testing in cornea banking with BacT/ALERT ® blood culture medium and automated detection system
Simone Hennerbichler, Austria

Chair: Frank Beneker, Richard Lomas

S8.1 Production and clinical distribution of a decellularized human dermis: the experience of Emilia Romagna Skin Bank
Valeria Purpura, Italy

17:45-18:00 | EATCB closing ceremony